“Long-Term Efficacy of Abrocitinib in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s329, https://doi.org/10.25251/skin.8.supp.329.